CC
ELV icon

ClearArc Capital’s Elevance Health ELV Stock Holding History

ClearArc Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$817K Sell
2,706
-1,162
-30% -$320K 0.32% 75
2019
Q3 		$929K Buy
3,868
+29
+0.8% +$7.95K 0.27% 91
2019
Q2 		$1.08M Sell
3,839
-478
-11% -$131K 0.32% 71
2019
Q1 		$1.24M Sell
4,317
-122
-3% -$35.3K 0.33% 70
2018
Q4 		$1.17M Sell
4,439
-2,276
-34% -$626K 0.35% 71
2018
Q3 		$1.84M Buy
6,715
+192
+3% +$49.8K 0.24% 98
2018
Q2 		$1.55M Buy
6,523
+1
+0% +$232 0.22% 104
2018
Q1 		$1.43M Buy
6,522
+8
+0.1% +$1.88K 0.22% 108
2017
Q4 		$1.47M Sell
6,514
-243
-4% -$51.8K 0.2% 116
2017
Q3 		$1.28M Buy
6,757
+265
+4% +$50.4K 0.19% 119
2017
Q2 		$1.22M Buy
6,492
+45
+0.7% +$8.09K 0.2% 125
2017
Q1 		$1.07M Buy
6,447
+59
+0.9% +$9.38K 0.18% 136
2016
Q4 		$918K Sell
6,388
-70
-1% -$9.37K 0.16% 144
2016
Q3 		$809K Buy
6,458
+71
+1% +$9.17K 0.15% 155
2016
Q2 		$839K Buy
6,387
+14
+0.2% +$1.92K 0.16% 142
2016
Q1 		$886K Sell
6,373
-296
-4% -$39.6K 0.19% 135
2015
Q4 		$930K Sell
6,669
-3,657
-35% -$504K 0.19% 141
2015
Q3 		$1.45M Buy
10,326
+3,777
+58% +$568K 0.3% 86
2015
Q2 		$1.07M Buy
6,549
+777
+13% +$124K 0.2% 137
2015
Q1 		$891K Buy
5,772
+9
+0.2% +$1.28K 0.18% 155
2014
Q4 		$724K Sell
5,763
-9,176
-61% -$1.13M 0.15% 178
2014
Q3 		$1.79M Buy
14,939
+3,402
+29% +$390K 0.4% 63
2014
Q2 		$1.24M Buy
11,537
+1,279
+12% +$132K 0.29% 107
2014
Q1 		$1.02M Sell
10,258
-672
-6% -$60.8K 0.25% 117
2013
Q4 		$1.01M Sell
10,930
-3,258
-23% -$289K 0.26% 113
2013
Q3 		$1.19M Sell
14,188
-632
-4% -$54.2K 0.33% 87
2013
Q2 		$1.21M Buy
+14,820
New +$1.11M 0.33% 90

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

ClearArc Capital's ELV Position: Q4 2019 in Review

ClearArc Capital reduced its Elevance Health (ELV) stake by 30% in Q4 2019, selling an estimated $320K and leaving 2,706 shares worth $817K. The position accounts for 0.32% of the portfolio, ranked #75.

ClearArc Capital first reported a position in ELV in Q2 2013 and has held it in 27 quarters since. The position peaked at $1.84M in Q3 2018. 1,111 funds tracked by Wall St. Rank hold ELV as of Q4 2019.

  • ClearArc Capital held 2,706 shares of Elevance Health worth $817K as of Q4 2019.
  • ClearArc Capital sold 1,162 Elevance Health shares in Q4 2019, an estimated $320K.
  • Elevance Health made up 0.32% of ClearArc Capital's portfolio in Q4 2019, its #75 holding.
  • ClearArc Capital first reported a position in Elevance Health in Q2 2013 and has held it in 27 quarters since.
  • ClearArc Capital's Elevance Health position peaked at $1.84M in Q3 2018.
  • 1,111 funds tracked by Wall St. Rank held Elevance Health as of Q4 2019.

Based on ClearArc Capital's 13F filing for Q4 2019, filed 14 Feb 2020.